Trade Summary

3 days ago, Coastlands Capital LP, serving as 10% owner Owner at ADIAL PHARMACEUTICALS, INC. (ADIL), purchased 25,000 shares at $2.60 per share, for a total transaction value of $65,000.00. Following this transaction, Coastlands Capital LP now holds 373,322 shares of ADIL.

This purchase represents a 7.18% increase in Coastlands Capital LP's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 29, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, July 1, 2026 at 10:30 AM ET, 2 days after the trade was made.

ADIAL PHARMACEUTICALS, INC. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.